Delivery Order SPE2DR25D2018-SPE2DR26FZ0C7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $27,766.85 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The Defense Logistics Agency awarded a delivery order valued at $12,931.15 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 MG tablets in a 30-count configuration, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract includes no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,618.73 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating competitive selection. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $3,366.17 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 5, 2025, with completion expected by December 8, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $3,371.93 delivery order for Ondansetron ODT 4 mg tablets (30-count) on November 28, 2025, with an ultimate completion date of December 1, 2025. This is a firm fixed-price, non-set-aside contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $27,358.58 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets in quantities of 30 units. This competitive award, executed on December 5, 2025, represents a firm fixed price delivery order with a completion date of December 8, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $4,865.43 delivery order to AmerisourceBergen Drug Corp on May 27, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of May 28, 2025. The contract is to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,688.52 to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count packages) on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed price, non-set-aside contract reflects a routine pharmaceutical procurement to support federal medical supply needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,644.86 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30, with an ultimate completion date of December 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $3,625.03 delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed price, non-set-aside contract with a completion date of December 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2018Indefinite Delivery Contract
- SPE2DR25D2018-SPE2DR26FZ0C7Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,987.57 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count packages) on December 9, 2025, with a completion date of December 10, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that enables comprehensive pharmaceutical and medical supply support to military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, regularly fulfills diverse pharmaceutical requirements for the Defense Logistics Agency and its medical supply chain. The company maintains an extensive portfolio of federal contracts covering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order for an anti-nausea medication exemplifies the company's ongoing role in supplying essential pharmaceuticals to support military and veteran healthcare operations through competitively awarded contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 12/8/25 |